Transferable Exclusivity Vouchers and Incentives for Antimicrobial Development in the European Union

, , &
Journal of Law, Medicine and Ethics 51 (1):213-216 (2023)
  Copy   BIBTEX

Abstract

The European Commission’s proposal to address antimicrobial resistance using transferable exclusivity vouchers (TEVs) is fundamentally flawed. European policymakers and regulators should consider alternatives, such as better funding for basic and clinical research, use of advance market commitments funded by a pay-or-play tax, or enacting an EU Fund for Antibiotic Development.

Categories

Keywords

Reprint years

DOI

10.1017/jme.2023.58

Other Versions

No versions found

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 100,448

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

My notes

Similar books and articles

Using the International Pandemic Instrument to Revitalize the Innovation Ecosystem for Antimicrobial R&D.Andrea Morales Caceres, Kshitij Kumar Singh, Timo Minssen, Susan Rogers Van Katwyk & Steven J. Hoffman - 2022 - Journal of Law, Medicine and Ethics 50 (S2):47-54.
Implementation of a Market Entry Reward within the United States.Gregory W. Daniel, Monika Schneider, Marianne Hamilton Lopez & Mark B. McClellan - 2018 - Journal of Law, Medicine and Ethics 46 (s1):50-58.
Approval and Withdrawal of New Antibiotics and other Antiinfectives in the U.S., 1980–2009.Kevin Outterson, John H. Powers, Enrique Seoane-Vazquez, Rosa Rodriguez-Monguio & Aaron S. Kesselheim - 2013 - Journal of Law, Medicine and Ethics 41 (3):688-696.
Stimulating Research and Development of New Antibiotics While Ensuring Sustainable Use and Access: Further Insights from the DRIVE-AB Project and Others.Esther Bettiol, Judith Hackett & Stephan Harbarth - 2018 - Journal of Law, Medicine and Ethics 46 (s1):5-8.
A Pandemic Instrument Can Start Turning Collective Problems into Collective Solutions by Governing the Common-Pool Resource of Antimicrobial Effectiveness.Isaac Weldon, Kathy Liddell, Susan Rogers Van Katwyk, Steven J. Hoffman, Timo Minssen, Kevin Outterson, Stephanie Palmer, A. M. Viens & Jorge Viñuales - 2022 - Journal of Law, Medicine and Ethics 50 (S2):17-25.
Evaluating the risks of public health programs: Rational antibiotic use and antimicrobial resistance.Annette Rid, Jasper Littmann & Alena Buyx - 2019 - Bioethics 33 (7):734-748.
Governance Processes and Challenges for Reservation of Antimicrobials Exclusively for Human Use and Restriction of Antimicrobial Use in Animals.J. Scott Weese, Guilherme Antonio Da Costa Junior, Bruno Gonzalez-Zorn, Laura Y. Hardefeldt, Jorge Matheu, Gerard Moulin, Stephen W. Page, Ruby Singh, Junxia Song & Olafur Valsson - 2022 - Journal of Law, Medicine and Ethics 50 (S2):55-63.
Antibiotics and Animal Agriculture: The need for global collective action.Jonny Anomaly - 2018 - In Michael Selgelid (ed.), Ethics and Antimicrobial Resistance. Oxford University Press. pp. 297-308.
Reducing the Ethical Burdens of Antimicrobial Stewardship using a Social Determinants Approach.Vijayaprasad Gopichandran - 2022 - Asian Bioethics Review 14 (2):183-190.
Antimicrobial resistance and antimicrobial stewardship programmes: benefiting the patient or the population?Alberto Giubilini - 2017 - Journal of Medical Ethics 43 (10):653-654.

Analytics

Added to PP
2023-07-31

Downloads
18 (#1,100,172)

6 months
5 (#1,015,253)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

No citations found.

Add more citations

References found in this work

No references found.

Add more references